Katapult Holdings' P/S remains below industry median despite share price surge due to its lower forecast growth. Investors see limited potential for revenue improvement, requiring a change of fortune for a higher P/S ratio.
Despite Katapult Holdings' recent share price increase, its P/S ratio still trails most other firms due to a weaker revenue outlook. Investors accept this as they don't foresee any significant future revenue surprises. A turn of luck is needed for a higher P/S justification.
MyMoo6293 :
The rocket doesn't seem to have been successful in taking off...it came down in a rather dramatic way. I am getting in now that it is making a turnaround.
Gainers: •$ベル(VERU.US)$+25.8% (announces that in a Pre-EUA meeting held May 10 2022 FDA has agreed that the efficacy and safety data from the completed Phase 3 clinical study in hospitalized COVID-19 patients at high risk for acute respiratory distress syndrome are sufficient to support the submission of a request for Emergency Use Authorization) •$デスクトップ・メタル(DM.US)$+15.8% (prices offering of $100 mln of 6.0% convertible se...
19
1
6
報告
我只想赚个买菜钱 :
NIO Pre-market UP 3.3%, before open market, immediately turned into RED. Only NIO able to do so. Haha.
カタパルト・ホールディングスに関するコメント
something very compelling about this chart
Beat Earnings Estimates *again*
コラムToday's pre-market stock movers: PTON, NIO, RBLX, U and more
• $ベル(VERU.US)$ +25.8% (announces that in a Pre-EUA meeting held May 10 2022 FDA has agreed that the efficacy and safety data from the completed Phase 3 clinical study in hospitalized COVID-19 patients at high risk for acute respiratory distress syndrome are sufficient to support the submission of a request for Emergency Use Authorization)
• $デスクトップ・メタル(DM.US)$ +15.8% (prices offering of $100 mln of 6.0% convertible se...
コラムTop upgrades and downgrades on 5/11
• $アークトゥルス・セラピューティクス・ホールディングス(ARCT.US)$ : Baird Upgrades to Neutral from Underperform - PT $18 (from $21)
• $アローヘッド・ファーマシューティカルズ(ARWR.US)$ : Baird Upgrades to Outperform from Neutral - PT $60 (from $71)
• $クロノス・グループ(CRON.US)$ : CIBC Upgrades to Outperformer from Neutral
• $HFシンクレア(DINO.US)$ : Cowen Upgrades to Outperform from Market Perform - PT $52 (from $38)
• $8X8(EGHT.US)$ : B. Riley Upgrades to Buy from Neutral - PT $13.50
• $ノバンタ(NOVT.US)$ : William...
No movement in this stock?
can someone pls advise. thanks
まだコメントはありません